Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001349929-20-000008
Filing Date
2020-06-24
Accepted
2020-06-24 16:42:07
Documents
69
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2020q1cgix331202010q.htm 10-Q 940222
2 EXHIBIT 31.1 q12020exhibit311certificat.htm EX-31.1 13547
3 EXHIBIT 31.2 q12020exhibit312certificat.htm EX-31.2 13396
4 EXHIBIT 32.1 q12020exhibit321certificat.htm EX-32.1 5274
5 EXHIBIT 32.2 q12020exhibit322certificat.htm EX-32.2 5200
  Complete submission text file 0001349929-20-000008.txt   6323586

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cgix-20200331.xml EX-101.INS 1292058
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgix-20200331.xsd EX-101.SCH 54200
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgix-20200331_cal.xml EX-101.CAL 125579
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgix-20200331_def.xml EX-101.DEF 259270
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgix-20200331_lab.xml EX-101.LAB 759311
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgix-20200331_pre.xml EX-101.PRE 436479
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

EIN.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35817 | Film No.: 20985932
SIC: 8071 Services-Medical Laboratories